These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37689083)

  • 21. Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study.
    Kasaie P; Schumacher CM; Jennings JM; Berry SA; Tuddenham SA; Shah MS; Rosenberg ES; Hoover KW; Gift TL; Chesson H; German D; Dowdy DW
    BMJ Open; 2019 Mar; 9(3):e023453. PubMed ID: 30837248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolving experience of hepatitis B virus prophylaxis in liver transplantation.
    Honaker MR; Shokouh-Amiri MH; Vera SR; Alloway RR; Grewal HP; Hardinger KL; Kizilisik AT; Bagous T; Trofe J; Stratta RJ; Egidi MF; Gaber AO
    Transpl Infect Dis; 2002 Sep; 4(3):137-43. PubMed ID: 12421458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low incidence and prevalence of hepatitis C in two cohorts of HIV pre-exposure prophylaxis adherence interventions in men who have sex with men in Southern California.
    Hassan A; Agustin HGS; Burke L; Kofron R; Corado K; Bolan R; Landovitz RJ; Dubé MP; Morris SR
    J Viral Hepat; 2022 Jul; 29(7):529-535. PubMed ID: 35357767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections.
    Tu T; Urban S
    Curr Opin Virol; 2018 Jun; 30():68-79. PubMed ID: 29775812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cabotegravir: The first long-acting injectable for HIV pre-exposure prophylaxis.
    Prather C; Jeon C
    Am J Health Syst Pharm; 2022 Oct; 79(21):1898-1905. PubMed ID: 35894204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of hepatitis B virus-active antiretroviral therapy against primary hepatitis B virus infection.
    Heuft MM; Houba SM; van den Berk GE; Smissaert van de Haere T; van Dam AP; Dijksman LM; Regez RM; Brinkman K
    AIDS; 2014 Apr; 28(7):999-1005. PubMed ID: 24685742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Piloting a partially self-financed mode of human immunodeficiency virus pre-exposure prophylaxis delivery for men who have sex with men in Hong Kong.
    Lee SS; Kwan TH; Wong NS; Lee KCK; Chan DPC; Lam TTN; Lui GCY
    Hong Kong Med J; 2019 Oct; 25(5):382-391. PubMed ID: 31619578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-exposure prophylaxis for Blood-Borne Viral (BBV) Infections.
    Chilaka VN; Hassan R; Konje JC
    Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():83-91. PubMed ID: 33113403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproductive considerations in the setting of chronic viral illness.
    Hanson BM; Dorais JA
    Am J Obstet Gynecol; 2017 Jul; 217(1):4-10. PubMed ID: 28209492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis.
    Shilaih M; Marzel A; Scherrer AU; Braun DL; Kovari H; Rougemont M; Darling K; Battegay M; Hoffmann M; Bernasconi E; Hirzel C; Günthard HF; Kouyos RD; ;
    J Infect Dis; 2016 Aug; 214(4):599-606. PubMed ID: 27190182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.
    Solomon MM; Schechter M; Liu AY; McMahan VM; Guanira JV; Hance RJ; Chariyalertsak S; Mayer KH; Grant RM;
    J Acquir Immune Defic Syndr; 2016 Mar; 71(3):281-6. PubMed ID: 26413853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report.
    Malahleha M; Ahmed K; Deese J; Nanda K; van Damme L; De Baetselier I; Burnett RJ
    J Med Case Rep; 2015 Sep; 9():207. PubMed ID: 26411737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occult hepatitis B and HIV infection.
    Soriano V; Aguilera A; Gonzalez R; Gomez-Gallego F; Barea L; Treviño M; Corral O
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1403-1407. PubMed ID: 30969194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Guideline 'Needlestick injuries': risk assessment and post-exposure management in practice].
    Ruijs WL; Timen A
    Ned Tijdschr Geneeskd; 2008 Sep; 152(36):1967-71. PubMed ID: 18807333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UK guideline for the use of HIV post-exposure prophylaxis 2021.
    Cresswell F; Asanati K; Bhagani S; Boffito M; Delpech V; Ellis J; Fox J; Furness L; Kingston M; Mansouri M; Samarawickrama A; Smithson K; Sparrowhawk A; Rafferty P; Roper T; Waters L; Rodger A; Gupta N
    HIV Med; 2022 May; 23(5):494-545. PubMed ID: 35166004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Online Navigation for Pre-Exposure Prophylaxis via PleasePrEPMe Chat for HIV Prevention: Protocol for a Development and Use Study.
    Weber S; Lazar L; McCord A; Romero C; Tan J
    JMIR Res Protoc; 2020 Sep; 9(9):e20187. PubMed ID: 32960183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV and hepatitis virus resistance to antivirals: review of data from the XIX International HIV and Hepatitis Virus Drug Resistance Workshop and curative strategies.
    Mascolini M; Mellors JW; Richman DD; Boucher CA; Larder BA
    Antivir Ther; 2011; 16(2):263-86. PubMed ID: 21447877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21.
    Giordano C; Picardi M; Pugliese N; Vincenzi A; Abagnale DP; De Fazio L; Giannattasio ML; Fatigati C; Ciriello M; Salemme A; Muccioli Casadei G; Vigliar E; Mascolo M; Troncone G; Pane F
    Front Oncol; 2023; 13():1130899. PubMed ID: 36890828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review.
    Bradshaw D; Taylor GP
    Front Med (Lausanne); 2022; 9():881547. PubMed ID: 35572998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
    Wang X; Nwokolo N; Korologou-Linden R; Hill A; Whitlock G; Day-Weber I; McClure MO; Boffito M
    HIV Med; 2018 Jan; 19(1):1-6. PubMed ID: 28657199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.